| | Cancer type | CSC markers reviewed in [1, 3, 6–8] | | Positive markers | Negative markers |
| | Leukemia | CD34, CD96, ALDH, CD47, CD44, CD123, TIM-3, CD32, CD25, CLL-1 | CD38 | | Prostate | ABCG2, ALDH, CD44, α2β1, CXCR4, CD133, NANOG, TRA-1-60, CD151, CD 166 | PSA, CK18, | | Bladder | CD44, CK5, CD44v6, 67LR, CK17, ALDH, SOX2 | CK20, EMA, CD66c, | | Breast | CD44, PKH26, CD49f, ALDH, CD133, CD90 | CD24 | | Lung | CD133, ALDH, CD117/c-kit, OCT4, NANOG, CD44, TPBG/5 T4, CD166, CD44, EpCAM | | | Pancreatic | CD44v6, α6β4, TSPAN8, CXCR4, CD44, CD24, ESA, c-Met, ALDH, CD133, | | | Glioblastoma | CD133, ABCG2, SSEA-1, SOX2, BMI1, MUSASHI1, NESTIN, OLIG2, CD49f, A2B5, L1CAM, EGFR, CD44, ID1, MYC, ALDH | | | Ovarian | ALDH, CD44, CD117/c-kit, CD44, MyD88, CD24, CD133, CXCR4 | | | Colon | CD133, EpCAM, CD44, CD166, ALDH, LGR5, ABCB5 | | | Liver | CD133, ALDH, EpCAM, CD90, CD44, CD13, SALL4 | CD45 |
|
|
